LLY

1,019.16

+2.69%↑

JNJ

210.09

+2.68%↑

ABBV

222.92

-0.29%↓

UNH

339.07

+4.39%↑

AZN

90.72

+0.2%↑

LLY

1,019.16

+2.69%↑

JNJ

210.09

+2.68%↑

ABBV

222.92

-0.29%↓

UNH

339.07

+4.39%↑

AZN

90.72

+0.2%↑

LLY

1,019.16

+2.69%↑

JNJ

210.09

+2.68%↑

ABBV

222.92

-0.29%↓

UNH

339.07

+4.39%↑

AZN

90.72

+0.2%↑

LLY

1,019.16

+2.69%↑

JNJ

210.09

+2.68%↑

ABBV

222.92

-0.29%↓

UNH

339.07

+4.39%↑

AZN

90.72

+0.2%↑

LLY

1,019.16

+2.69%↑

JNJ

210.09

+2.68%↑

ABBV

222.92

-0.29%↓

UNH

339.07

+4.39%↑

AZN

90.72

+0.2%↑

Search

Omnicell Inc

Abrir

SetorSaúde

42.96 -2.03

Visão Geral

Variação de preço das ações

24h

Atual

Mín

43.02

Máximo

44.77

Indicadores-chave

By Trading Economics

Rendimento

-177K

5.5M

Vendas

20M

311M

P/E

Médio do Setor

101.279

77.671

EPS

0.51

Margem de lucro

1.758

Funcionários

3,600

EBITDA

524K

31M

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+6.53% upside

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

598M

2B

Abertura anterior

44.99

Fecho anterior

42.96

Sentimento de Notícias

By Acuity

46%

54%

188 / 374 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Strong Bearish Evidence

Omnicell Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

10 de dez. de 2025, 22:02 UTC

Ganhos

Synopsys Sees Strong 2026 as Ansys Acquisition Boosts 4Q Revenue

10 de dez. de 2025, 21:46 UTC

Ganhos

Adobe Expects Double-Digit Recurring Revenue Growth Next Year

10 de dez. de 2025, 23:52 UTC

Aquisições, Fusões, Aquisições de Empresas

Paramount Sends Letter to Warner Bros. Shareholders Saying Its Offer Is 'Superior' -- Barrons.com

10 de dez. de 2025, 23:43 UTC

Conversa de Mercado

Nikkei May Rise After Fed Rate Cut -- Market Talk

10 de dez. de 2025, 23:36 UTC

Conversa de Mercado

Gold Consolidates as Traders Digest FOMC Decision -- Market Talk

10 de dez. de 2025, 23:20 UTC

Ganhos

Oracle Reports $16.1 Billion in Revenue, Narrowly Missing Forecasts -- 2nd Update

10 de dez. de 2025, 23:15 UTC

Ganhos

Synopsys Targets Double-Digit Growth Following Ansys Acquisition -- Interview

10 de dez. de 2025, 22:59 UTC

Conversa de Mercado
Ganhos
Aquisições, Fusões, Aquisições de Empresas

Adobe Expects Semrush Deal to Bring in New Users -- Market Talk

10 de dez. de 2025, 22:45 UTC

Conversa de Mercado

Coca-Cola's New CEO Pick Looks A Lot Like The Last One -- Market Talk

10 de dez. de 2025, 22:40 UTC

Ganhos

Synopsys Stock Rises on Earnings Beat, Higher Guidance -- Barrons.com

10 de dez. de 2025, 22:06 UTC

Aquisições, Fusões, Aquisições de Empresas

Paramount Sends Letter to Warner Bros. Shareholders Saying Their Offer Is 'Superior' -- Barrons.com

10 de dez. de 2025, 22:06 UTC

Ganhos

Oracle Reports Mixed Earnings. The Stock Is Falling. -- Barrons.com

10 de dez. de 2025, 22:02 UTC

Ganhos

Synopsys Stock Rises on Earnings Beat, Higher Guidance -- Barrons.com

10 de dez. de 2025, 22:00 UTC

Ganhos

Oracle Reports $16.1 Billion in Revenue, Narrowly Missing Forecasts -- Update

10 de dez. de 2025, 21:53 UTC

Ganhos

Adobe Earnings Show 'Rapid Adoption' of AI Tools. The Stock Is Up. -- Barrons.com

10 de dez. de 2025, 21:50 UTC

Aquisições, Fusões, Aquisições de Empresas

Investors Bet That a Higher Bid for Warner Is Coming -- Update

10 de dez. de 2025, 21:50 UTC

Conversa de Mercado
Ganhos
Aquisições, Fusões, Aquisições de Empresas

Financial Services Roundup: Market Talk

10 de dez. de 2025, 21:50 UTC

Conversa de Mercado

Health Care Roundup: Market Talk

10 de dez. de 2025, 21:50 UTC

Conversa de Mercado

Auto & Transport Roundup: Market Talk

10 de dez. de 2025, 21:45 UTC

Aquisições, Fusões, Aquisições de Empresas

Paramount Sends Letter to Warner Bros. Shareholders Saying Their Offer Is 'Superior' -- Barrons.com

10 de dez. de 2025, 21:33 UTC

Ganhos

Oracle Reports $16.1 Billion in Revenue, Narrowly Missing Forecasts -- WSJ

10 de dez. de 2025, 21:32 UTC

Ganhos

Oracle Reports Mixed Earnings. The Stock Is Falling. -- Barrons.com

10 de dez. de 2025, 21:28 UTC

Aquisições, Fusões, Aquisições de Empresas

Sverica Capital Management Announces Sale of Coastal Cloud Holdings to Tata Consultancy Services for $700M

10 de dez. de 2025, 21:25 UTC

Ganhos

Adobe Earnings Show 'Rapid Adoption' of AI Tools. The Stock Is Up. -- Barrons.com

10 de dez. de 2025, 21:18 UTC

Aquisições, Fusões, Aquisições de Empresas

Paramount Skydance: Company Has Air Tight Financing to Deliver on Warner Bros. Offer >PSKY

10 de dez. de 2025, 21:16 UTC

Ganhos

Oracle Reports Mixed Earnings. The Stock is Falling. -- Barrons.com

10 de dez. de 2025, 21:15 UTC

Aquisições, Fusões, Aquisições de Empresas

Paramount Skydance: Public Offer for Warner Bros. Delivers Superior Value, Faster, More Certain Path to Completion

10 de dez. de 2025, 21:15 UTC

Ganhos

Oracle: 'Sold Ampere Because We No Longer Think It Is Strategic for Us to Continue Designing, Manufacturing and Using Our Own Chips in Our Cloud Datacenters' >ORCL

10 de dez. de 2025, 21:14 UTC

Ganhos

Oracle 2Q Non-GAAP Operating Income Was $6.7 B >ORCL

10 de dez. de 2025, 21:14 UTC

Ganhos

Oracle 2Q GAAP Operating Income Was $4.7 B >ORCL

Comparação entre Pares

Variação de preço

Omnicell Inc Previsão

Preço-alvo

By TipRanks

6.53% parte superior

Previsão para 12 meses

Média 46.33 USD  6.53%

Máximo 50 USD

Mínimo 43 USD

Com base em 4 analistas de Wall Street que oferecem metas de preço de 12 meses para Omnicell Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

4 ratings

3

Comprar

1

Manter

0

Vender

Pontuação Técnica

By Trading Central

24.23 / 30.44Suporte e Resistência

Curto Prazo

Strong Bearish Evidence

Médio Prazo

Strong Bearish Evidence

Longo Prazo

Bearish Evidence

Sentimento

By Acuity

188 / 374 Ranking em Saúde

Sentimento de Notícias

Evidência de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Acima da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Omnicell Inc

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
help-icon Live chat